Find a copy in the library
Finding libraries that hold this item...
Details
Genre/Form: | Thèses et écrits académiques |
---|---|
Material Type: | Thesis/dissertation |
Document Type: | Book |
All Authors / Contributors: |
Morgane Régeard; Jean-Pierre Gangneux; Agrocampus Rennes |
OCLC Number: | 494612262 |
Description: | 1 vol. (189 p.) : ill. ; 24 cm. |
Responsibility: | Régeard, Morgane J. ; sous la dir. de Gangneux, Jean-Pierre. |
Abstract:
Hepatitis C virus (HCV) is a human pathogen responsible for liver diseases including acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma. Its high prevalence, the absence of a prophylactic vaccine and the poor efficiency of current therapies raises huge medical problems. In order to control HCV infection and to develop direct or indirect antivirals, our knowledge of the virus has to be improved. Hepatitis C virus has been identified in 1989 and is an developed, positive-stranded virus classified in the Flaviridae family. The development of HCV pseudoparticles in 2003 and, most recently, in 2005 of cell culture grown HCV allowed the study of the early event occurring during infection of hepatoma cell lines. The originality of this work is to make use of an in vitro infection model base on the infection of human hepatocytes in primary culture by HCV particles contained in the sera of infected individuals. This model is closed to the physiological situation of infection and reproduces the entire life cycle of HCV. In this infection system, three different research projects have been developed to decipher the early event of infection.
Reviews

